We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$697M
AUM Growth
+$48.1M
Cap. Flow
+$16.4M
Cap. Flow %
2.35%
Top 10 Hldgs %
74.61%
Holding
140
New
62
Increased
24
Reduced
32
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 10.67%
2 Energy 1.98%
3 Technology 0.46%
4 Consumer Discretionary 0.12%
5 Industrials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
51
AbbVie
ABBV
$450B
$1.54M 0.22%
9,646
+3,893
+68% +$595K
ZBH icon
52
Zimmer Biomet
ZBH
$17.4B
$1.51M 0.22%
+11,697
New +$1.47M
BDX icon
53
Becton Dickinson
BDX
$42.7B
$1.5M 0.22%
6,065
+2,672
+79% +$654K
IDXX icon
54
Idexx Laboratories
IDXX
$44.4B
$1.47M 0.21%
+2,939
New +$1.41M
UNH icon
55
UnitedHealth
UNH
$382B
$1.26M 0.18%
2,662
-5,335
-67% -$2.57M
NET icon
56
CALL
Cloudflare
NET
$98.5B
$1.22M 0.18%
19,800
-38,000
-66% -$2.08M
ALLO icon
57
Allogene Therapeutics
ALLO
$614M
$1.21M 0.17%
+245,000
New +$1.57M
TCRX icon
58
TScan Therapeutics
TCRX
$58.6M
$1.15M 0.16%
+546,916
New +$1.3M
COO icon
59
Cooper Companies
COO
$13.8B
$1.14M 0.16%
12,164
+5,460
+81% +$469K
DXCM icon
60
DexCom
DXCM
$29.5B
$1.1M 0.16%
9,488
-12,086
-56% -$1.35M
MRNS
61
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.03M 0.15%
+150,000
New +$941K
STOK icon
62
Stoke Therapeutics
STOK
$1.74B
$1.02M 0.15%
+122,796
New +$1.11M
TMO icon
63
Thermo Fisher Scientific
TMO
$195B
$995K 0.14%
1,727
-520
-23% -$293K
EIGR
64
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$986K 0.14%
+36,655
New +$1.7M
KURA icon
65
Kura Oncology
KURA
$959M
$978K 0.14%
+80,000
New +$998K
RVTY icon
66
Revvity
RVTY
$12B
$905K 0.13%
+6,788
New +$894K
ABT icon
67
Abbott
ABT
$177B
$850K 0.12%
8,394
-2,500
-23% -$264K
RMD icon
68
ResMed
RMD
$28.4B
$782K 0.11%
3,572
-6,097
-63% -$1.32M
MSFT icon
69
Microsoft
MSFT
$2.94T
$773K 0.11%
+2,680
New +$684K
ELV icon
70
Elevance Health
ELV
$82.7B
$744K 0.11%
1,619
-2,818
-64% -$1.34M
AMED
71
DELISTED
Amedisys
AMED
$705K 0.1%
+9,590
New +$830K
GILD icon
72
Gilead Sciences
GILD
$166B
$700K 0.1%
8,438
+4,176
+98% +$346K
CRWD icon
73
CALL
CrowdStrike
CRWD
$208B
$673K 0.1%
19,600
ESTA icon
74
Establishment Labs
ESTA
$2.72B
$656K 0.09%
9,688
-25,840
-73% -$1.77M
LQD icon
75
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35B
$622K 0.09%
+5,675
New +$615K

Similar funds

Simplify Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Simplify Asset Management held 140 positions worth $697M, up 7.4% from $649M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Simplify Asset Management's Q1 2023 filing shows 62 new, 24 increased, 32 reduced and 21 closed positions. Its largest new stake was iShares iBonds Dec 2023 Term Corporate ETF: 800,000 shares worth $20.2M. The largest sale was iShares Core S&P 500 ETF, an estimated $153M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 8.1% a quarter earlier, followed by Energy and Technology.

  • Simplify Asset Management's largest Q1 2023 buy was iShares iBonds Dec 2023 Term Corporate ETF: 800,000 shares worth $20.2M.
  • Simplify Asset Management added most to Simplify Aggregate Bond ETF in Q1 2023, an estimated $4.25M increase.
  • Simplify Asset Management's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $153M.
  • Simplify Asset Management fully exited Cigna in Q1 2023, selling an estimated $2.93M.
  • Simplify Asset Management's ten largest holdings make up 75% of its $697M portfolio in Q1 2023.
  • Simplify Asset Management opened 62 new positions and closed 21 in Q1 2023.
  • Simplify Asset Management's portfolio value rose 7.4% quarter-over-quarter to $697M.

Based on Simplify Asset Management's 13F filing for Q1 2023, filed 10 May 2023.